The majority of peptides are administered via subcutaneous injection — a short, fine needle into the fatty tissue just below the skin. For most people new to self-injection, the anticipation is worse than the act itself. A 31 gauge insulin syringe is barely perceptible. The technique is learnable in a single session.
This guide covers the two injection routes used for peptides and hormones — subcutaneous (SubQ) and intramuscular (IM) — the equipment required, site selection, step-by-step technique, and what normal post-injection reactions look like. It also covers the most common beginner mistakes and how to avoid them.
Peptides need to be properly reconstituted with bacteriostatic water before injection. If you have not yet reconstituted your peptide, see the peptide reconstitution guide first. The reconstitution calculator will help you work out the exact volume to draw for your target dose.
SubQ vs IM — When Each Route Is Used
The two routes differ in where the needle terminates: subcutaneous injections deposit the compound into the layer of fat directly below the skin, while intramuscular injections deposit it into muscle tissue. The choice affects absorption speed, comfort, and which needle length is appropriate.
Subcutaneous injection is used for the vast majority of peptides — BPC-157, TB-500, GHK-Cu, CJC-1295, Ipamorelin, semaglutide, tirzepatide, retatrutide, and most others. SubQ is chosen because it produces slower, more sustained absorption from the depot that forms in fatty tissue, which is pharmacokinetically appropriate for most peptide compounds. It is also more comfortable and easier to self-administer.
Intramuscular injection is used for oil-based compounds that require it for proper suspension and absorption — most commonly testosterone esters, NPP, and similar anabolic compounds. IM injections deposit into larger muscle groups (ventrogluteal, vastus lateralis, deltoid), use longer needles, and produce faster peak absorption than SubQ.
| Route | Needle Length | Gauge | Common Compounds | Absorption |
|---|---|---|---|---|
| SubQ | 8mm (5/16") | 29–31g | Most peptides, GLP-1s | Slow, sustained |
| IM | 25–38mm (1–1.5") | 23–25g | Test esters, NPP, oil-based | Faster peak |
Equipment You Need
For SubQ peptide injections, the supply list is short. You do not need much. The most important choice is needle gauge — finer is more comfortable but slightly slower to draw.
- Insulin syringes: 0.5ml or 1ml capacity, 29–31 gauge, 8mm (5/16") needle. These are available at most pharmacies without a prescription. A 1ml syringe is more practical if you are drawing more than 50 units of volume.
- Bacteriostatic water (BAC water): Used to reconstitute lyophilized (freeze-dried) peptide powder. Standard BAC water is 0.9% benzyl alcohol as a preservative. Do not use sterile water for injection (it has no preservative and will degrade the peptide within days).
- Alcohol swabs (70% isopropyl): For swabbing the vial septum before every draw and the injection site before every pin. Allow to air-dry before drawing or injecting.
- Sharps container: A proper sharps disposal container. Never recap and discard used needles in regular trash. Sharps containers are inexpensive and available at pharmacies.
- Optional — drawing needle: A larger gauge needle (18–21g) used only to draw from the vial, then swapped for the fine injection needle. This prevents dulling the fine needle on the rubber septum before it enters skin.
SubQ Injection — Step by Step
The following sequence is the standard technique for subcutaneous self-injection. Take your time on the first few. Familiarity arrives quickly and the process becomes routine within a week.
Prepare your workspace
Wash your hands thoroughly with soap and water. Work on a clean, flat surface. Lay out your syringe, vial, alcohol swabs, and sharps container before starting. Confirm the peptide vial is the correct compound and that your reconstituted solution is within its stable storage window — most reconstituted peptides are stable for 2–4 weeks refrigerated.
Swab the vial and draw your dose
Wipe the rubber septum of the peptide vial with an alcohol swab and allow it to air-dry for 10–15 seconds. Draw air into the syringe equal to your target volume, insert the needle into the vial, push the air in, then invert the vial and draw your dose. Tap the syringe gently and push out any air bubbles with the plunger before withdrawing the needle. Confirm the volume drawn against your calculated dose — the reconstitution calculator shows exactly how many units to draw for any target dose.
Choose and prepare your injection site
The three most commonly used SubQ sites are the abdomen (2–3 inches from the navel, avoiding the immediate periumbilical area), the outer thigh (anterior-lateral surface, mid-thigh), and the back of the upper arm (posterior triceps area). The abdomen is the most accessible for self-injection and has a generous SubQ fat layer in most people.
Wipe the site with an alcohol swab and allow to air-dry. Cold, wet skin from alcohol makes injections more uncomfortable — always let it dry fully.
Pinch the skin and insert at 45 degrees
Using your non-dominant hand, pinch a fold of skin between thumb and forefinger — lifting the subcutaneous fat layer away from the muscle beneath it. With your dominant hand, hold the syringe like a dart and insert the needle at a 45-degree angle in a single smooth, confident motion. Hesitating or going slow increases discomfort. The needle should be fully inserted up to where the needle meets the barrel (the hub).
Leaner individuals with less subcutaneous fat should always use 45 degrees. Those with more fat may use 90 degrees, which is slightly more practical for the abdomen.
Inject slowly and withdraw
Release the skin pinch and slowly depress the plunger over 3–5 seconds. Fast injection is associated with more discomfort and a higher likelihood of leakback. Once the plunger is fully depressed, withdraw the needle at the same angle it entered, then immediately apply light pressure with a dry swab (not alcohol — this stings on fresh puncture). Do not rub. Immediately dispose of the syringe in the sharps container.
Aspiration — pulling back the plunger to check for blood before injecting — is no longer considered necessary for SubQ injections. Current guidance from major health organizations does not require it for SubQ administration. The subcutaneous fat layer does not contain blood vessels large enough to produce a meaningful intravascular injection at standard sites. If blood appears in the barrel during a draw, withdraw, discard, and start with a fresh syringe.
Injection Site Rotation
Repeated injection into the same spot causes lipohypertrophy — a buildup of fibrous and fatty scar tissue at the injection site. It presents as a firm lump under the skin, is not harmful but is cosmetically noticeable, and — crucially — impairs absorption because the altered tissue changes the diffusion characteristics of the depot. People who injected insulin into the same site for years noticed this effect first.
A practical rotation scheme for daily SubQ dosers uses a minimum of 5–7 distinct sites per rotation cycle, allowing each site to rest for at least a week before reuse. A common approach is to divide the abdomen into a grid of 6–8 numbered sites (three on each side of the navel, upper and lower rows) and rotate through them systematically, then transition to thigh sites when needed.
- Abdomen: Divide the area around the navel into a clock face. Avoid the central 2 inches around the navel and any visible veins. Sites at 2, 4, 7, 10 o'clock on both sides give 8 distinct points.
- Outer thigh: The anterior-lateral thigh (top of the leg, toward the outside) offers two distinct sites per leg — upper and lower mid-thigh. Avoid the inner thigh and any visible vasculature.
- Upper arm / deltoid: The posterior tricep area works for SubQ but is harder to self-administer cleanly. More practical when someone else is assisting.
Milligram's dose logging tracks which compounds you have administered each day, making it straightforward to keep an accurate record of injection frequency — useful when managing site rotation across a multi-compound protocol.
Intramuscular Injection — Technique Overview
IM injection is most commonly required for testosterone esters (testosterone enanthate, testosterone cypionate) and other oil-based compounds. The technique differs from SubQ in needle length, gauge, angle, and muscle site selection.
Ventrogluteal Site (Preferred)
The ventrogluteal site — the gluteus medius muscle on the side of the hip — is widely considered the safest IM injection site by nursing and pharmacology literature. It has a thick muscle mass, no major nerves or blood vessels near the surface, and is accessible for self-injection. To locate it: place the heel of your hand on the greater trochanter (the bony prominence on the outside of your hip), point your index finger toward the anterior superior iliac spine (the front of your hip bone), and point your middle finger backward along the iliac crest. Inject into the V formed between the fingers.
Vastus Lateralis (Outer Thigh)
The vastus lateralis — the outer head of the quadriceps — is the most commonly used self-injection IM site because of its accessibility. Inject into the middle third of the outer thigh (not the top or bottom) with a 1–1.5 inch needle. This is a large muscle with minimal neurovascular risk when the correct zone is used.
For IM, inject at a 90-degree angle without a skin pinch. Insert in a smooth, single motion to the hub, depress the plunger over 10 seconds, then withdraw smoothly. Applying light pressure and massaging the site afterward can help distribute the oil through the muscle and reduce post-injection discomfort.
Normal Injection Site Reactions
Several post-injection reactions are entirely normal and do not indicate a problem:
- Minor redness or warmth: A small red mark at the injection site lasting 15–30 minutes is a normal inflammatory response to the needle puncture. This is not an infection.
- Small bump under the skin: A small raised area immediately after SubQ injection is the depot forming in the fat layer. This resolves within 30–60 minutes as the solution disperses.
- Minor bruising: Occasional bruising, particularly at abdominal sites, is common. It indicates a small capillary was nicked. Not harmful. Applying light pressure immediately after withdrawal reduces frequency.
- Mild post-injection soreness (IM): Some soreness in the injected muscle over 24–48 hours after IM injection is normal, particularly with first injections or higher volumes. Warming the oil to body temperature before injection and injecting slowly both reduce this effect.
Increasing redness, swelling, and warmth that worsens over 24–48 hours (rather than improving), a hot lump that develops at the injection site, systemic fever, or tracking red lines from the site are not normal post-injection responses and warrant attention from a healthcare professional. These presentations are uncommon when proper aseptic technique is followed.
Managing First Injection Anxiety
A high proportion of first-time injectors report that the anticipation of the first injection is significantly more uncomfortable than the injection itself. The needle gauge used for SubQ is the same as that used for insulin — a 31g needle is finer than many acupuncture needles. The sensation is commonly described as a slight pinch, not a sharp pain.
A few techniques that many users find helpful on the first injection: inject immediately after a warm shower (warm skin is more relaxed), use a pinch technique even if your body composition doesn't strictly require it (it slightly desensitises the skin), and inject with a single confident motion rather than gradually — slower is paradoxically more uncomfortable because it gives more time to anticipate.
Within a week of consistent injections, the process typically becomes mechanical — something done quickly before bed or in the morning with no more psychological weight than taking an oral supplement. The technique normalises fast.
Frequently Asked Questions
Does subcutaneous injection hurt?
Most people report SubQ injections with a 29–31 gauge insulin syringe as a minor pinch — significantly less discomfort than intramuscular injections. The needle is fine and short. Injecting into warm, dry skin with a confident motion produces the least sensation. Many experienced users describe it as barely noticeable after the first week.
How deep does a SubQ injection need to go?
A standard 8mm (5/16 inch) insulin syringe inserted at a 45-degree angle with a skin pinch is sufficient for the subcutaneous fat layer in the vast majority of people. The full length of the needle should be inserted — inserting only partway is a common beginner mistake that deposits the compound too shallowly, increasing leakback and potential skin irritation.
Do you need to aspirate before injecting?
Aspiration is not considered necessary for subcutaneous injections and has been formally removed from recommendations by major health organisations including the WHO. The subcutaneous fat layer does not contain blood vessels large enough to present a meaningful intravascular injection risk at standard sites. For IM injections, practices vary — current clinical guidance in many countries no longer requires aspiration for IM either, but this remains an area where individual practitioner guidance may differ.
Can you inject in the same spot every day?
Repeated injection at the same site is associated with lipohypertrophy — hardening and thickening of the subcutaneous tissue from repeated trauma. This can impair absorption and becomes cosmetically noticeable. A rotation scheme using at least 5–7 sites per cycle and resting each site for a week between injections is widely used to prevent this. Tracking which sites have been used recently is a practical part of managing a consistent daily injection protocol.
What needle gauge should I use for peptides?
29–31 gauge insulin syringes (0.5ml or 1ml, 8mm length) are the standard for SubQ peptide injections. 31 gauge is the finest and most comfortable but draws slightly slower. 29 gauge draws faster and is still very comfortable. For IM injections of oil-based compounds, 23–25 gauge 1–1.5 inch needles are more typical — finer gauges struggle with thick oils and may require excessive force to inject, increasing the risk of needle separation.